Phenylisopropylamine en es it fr

Phenylisopropylamine Brand names, Phenylisopropylamine Analogs

Phenylisopropylamine Brand Names Mixture

  • Adderall (amphetamine + dextroamphetamine)
  • Adderall XR 10mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 15mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 20mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 25mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 30mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)
  • Adderall XR 5mg (Amphetamine Aspartate + Amphetamine Sulfate + Dextroamphetamine Saccharate + Dextroamphetamine Sulfate)

Phenylisopropylamine Chemical_Formula

C9H13N

Phenylisopropylamine RX_link

http://www.rxlist.com/cgi/generic3/adderallxr.htm

Phenylisopropylamine fda sheet

Phenylisopropylamine msds (material safety sheet)

Phenylisopropylamine Synthesis Reference

U. S. Pat. 1,879,003, (1932)

Phenylisopropylamine Molecular Weight

135.206 g/mol

Phenylisopropylamine Melting Point

Volatizes slowly at room temperature

Phenylisopropylamine H2O Solubility

Slightly

Phenylisopropylamine State

Solid

Phenylisopropylamine LogP

1.799

Phenylisopropylamine Dosage Forms

Capsules

Phenylisopropylamine Indication

For treatment of Attention Deficit Disorder with Hyperactivity (ADDH) and narcolepsy in children.

Phenylisopropylamine Pharmacology

Amphetamine and dextroamphetamine, non-catechloamine sypathomimetic agents, are used in combination to treat attention-deficit hyperactivity disorder (ADHD) or narcolepsy. Adderall consists of equivalent amounts of amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate.

Phenylisopropylamine Absorption

It forms easily absorbed molecules that are highly lipid soluble

Phenylisopropylamine side effects and Toxicity

LD50=180 mg/kg(s.c in rat). The most common presenting symptoms seen are agitation, hallucinations, suicidal behaviour, and chest pain.

Phenylisopropylamine Patient Information

Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.

Phenylisopropylamine Organisms Affected

Humans and other mammals